Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 0.125 USD 1.13% Market Closed
Market Cap: 18m USD

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 1.785 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.

Lowest
Price Target
1.01 USD
708% Upside
Average
Price Target
1.785 USD
1 328% Upside
Highest
Price Target
2.1 USD
1 580% Upside
Applied Therapeutics Inc Competitors:
Price Targets
2480
Beijing Luzhu Biotechnology Co Ltd
37% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
28% Upside
87S
Roivant Sciences Ltd
15% Upside
VCYT
Veracyte Inc
15% Upside
CANTA
Cantargia AB
113% Upside
TNG
Transgene SA
77% Upside
IMTX
Immatics NV
81% Upside
1801
Innovent Biologics Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Applied Therapeutics Inc

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 4 years is 248%.

N/A
Past Growth
248%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Price Target
1.785 USD

According to Wall Street analysts, the average 1-year price target for APLT is 1.785 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
248%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 4 years is 248%.

Back to Top